Clinical Trial Update: Cabergoline in Metastatic Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial updates the clinical trial of cabergoline in recurrent/metastatic breast cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Northwestern University | Conditions: Recurrent Breast Cancer, Stage IV Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-03-26